Overview
Sabine Reiterer-Cerny practices practicing medicine in Vienna, Austria.
Ms. Reiterer-Cerny is highly rated in 5 conditions, according to our data. Her clinical expertise encompasses Mast Cell Activation Syndrome (MCAS), Systemic Mastocytosis, Chronic Myelogenous Leukemia (CML), and Leukemia.
She is actively involved in clinical research, co-authoring 39 peer reviewed articles.
Gender
Locations
Clinical Research
Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Experts who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.
Frequently Asked Questions about Sabine Reiterer-Cerny
Is Sabine Reiterer-Cerny a top-rated expert for Mast Cell Activation Syndrome (MCAS)?
MediFind is an objective health platform that identifies experts based on real-world data. Sabine Reiterer-Cerny is classified as an Distinguished expert for Mast Cell Activation Syndrome (MCAS), meaning they are among the top experts in the country for this condition. This ranking is based on their volume of patients, published research, and peer connections.
Does Sabine Reiterer-Cerny participate in research or clinical trials?
Yes. Sabine Reiterer-Cerny has published 39 articles and abstracts on conditions like Mast Cell Activation Syndrome (MCAS). You can view a list of Sabine Reiterer-Cerny's latest peer-reviewed publications and clinical trial participation on their profile to see if they are active in new treatments.
Areas of Expertise
MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.
Learn more about MediFind’s expert tiers
- Distinguished
- Chronic Myelogenous Leukemia (CML)Ms. Reiterer-Cerny isDistinguished. Learn about Chronic Myelogenous Leukemia (CML).
- Mast Cell Activation Syndrome (MCAS)Ms. Reiterer-Cerny isDistinguished. Learn about Mast Cell Activation Syndrome (MCAS).
- Systemic MastocytosisMs. Reiterer-Cerny isDistinguished. Learn about Systemic Mastocytosis.
- Advanced
- Acute Myeloid Leukemia (AML)Ms. Reiterer-Cerny isAdvanced. Learn about Acute Myeloid Leukemia (AML).
- LeukemiaMs. Reiterer-Cerny isAdvanced. Learn about Leukemia.
- Experienced
- Acute Lymphoblastic Leukemia (ALL)Ms. Reiterer-Cerny isExperienced. Learn about Acute Lymphoblastic Leukemia (ALL).
- AtherosclerosisMs. Reiterer-Cerny isExperienced. Learn about Atherosclerosis.
- Essential ThrombocythemiaMs. Reiterer-Cerny isExperienced. Learn about Essential Thrombocythemia.
- Myelodysplastic Syndrome (MDS)Ms. Reiterer-Cerny isExperienced. Learn about Myelodysplastic Syndrome (MDS).
- MyelofibrosisMs. Reiterer-Cerny isExperienced. Learn about Myelofibrosis.
- Myeloproliferative Neoplasms (MPN)Ms. Reiterer-Cerny isExperienced. Learn about Myeloproliferative Neoplasms (MPN).
- Polycythemia VeraMs. Reiterer-Cerny isExperienced. Learn about Polycythemia Vera.